07:52 AM EST, 02/10/2025 (MT Newswires) -- Pliant (PLRX) shares were down nearly 64% pre-bell Monday after the company said late Friday it has suspended enrollment and treatment in a phase 2b trial of bexotegrast for idiopathic pulmonary fibrosis.

Semtech ( SMTC ) stock was more than 27% lower, adding to Friday's losses.

Bellevue Life Science Acquisition (BLAC) shares were down 8% lower after a 1.6% loss in the previous session.